Rchr
J-GLOBAL ID：200901043722528823
Update date: Apr. 17, 2024
Satoh Noriko
サトウ ノリコ | Satoh Noriko
Affiliation and department：
Teikyo University Faculty of Pharmaceutical Sciences, 物理薬剤学教室
About Teikyo University Faculty of Pharmaceutical Sciences, 物理薬剤学教室
Search "Teikyo University Faculty of Pharmaceutical Sciences, 物理薬剤学教室"
Detailed information
Job title：
Research Assistant
Research field (2)：
Pharmacology
, Pharmaceuticals - health and biochemistry
Research keywords (4)：
PLA2
, PAF
, PLA2
, PAF
Research theme for competitive and other funds (6)：
羊赤血球膜に結合する新規PLA
2
の同定
羊赤血球の膜結合型PLA2の精製
ラット脳におけるコリントランスフェラーゼによるPAFの生合成
Identification of novel phospholipase A
2
located in sheep erythrocyte membrane
Purified Phospholipase A2 from Sheep Erythrocyte Membrane
BLOSYNTHESIS OF PAF BY CHOLINEPHOSPHOTRANSFERASE IN VARIOUS RAT BRAIN
Show all
MISC (15)：
Ken Karasawa, Mariko Shirakura, Ayako Harada, Noriko Satoh, Kazuaki Yokoyama, Morio Setaka, Keizo Inoue. Red Blood Cells Highly Express Type I Platelet-Activating Factor-Acetylhydrolase(PAF-AH) Which Consists of the α1/α2 Complex. J. Biochem. 2005. 138. 4. 509-517
Plasma Platelet Activating Factor-Acetylhydrolase (PAF-AH). Progress in Lipid Research. 2003. 42,93-114
Regulation of Activities of Cytidine 5'-Diphosphocholine: 1-O-Alkyl-2-Acetyl-sn-Glycerol Cholinephosphotransferase,an Enzyme Responsible for de novo Synthesis of Platelet-Activating Factor,by Membrane Phospholipids. Fournal of Health Science. 2003. 49,13-21
Deficient platelet-activating factor and related enzymes in hemimegalencephaly (jointly worked). Child's Nerv Syst. 1999. 15. 98-102
T Sasaki, T Tohyama, K Oda, H Toyama, SI Ishii, M Senda, K Karasawa, N Satoh, M Setaka, S Nojima, et al. A distribution study of C-11 platelet-activating factor (PAF) analogs in normal and tumor-bearing mice. NUCLEAR MEDICINE AND BIOLOGY. 1996. 23. 3. 309-314
ｍore...
Association Membership(s) (3)：
日本脂質生化学研究会
, 日本生化学会
, 日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
